COMMUNIQUÉS West-GlobeNewswire

Catalyst Biosciences Initiates Phase 2/3 Trial of Marzeptacog Alfa (activated) for Prophylaxis in Hemophilia A or B with Inhibitors

04/01/2018 - 14:00

Currently Enrolling Individuals with Hemophilia A or B with Inhibitors Interim Data Expected During the First Half of 2018 SOUTH SAN FRANCISCO, Calif., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. ( [...]

Foamix Announces Positive Results from Phase 3 Open-Label Safety Extension Evaluating FMX-101 Topical Minocycline Foam for Treatment up to 1 Year

04/01/2018 - 14:00

Long Term Data on FMX-101 in Moderate-to-Severe Acne to be Presented at Winter Clinical Dermatology Conference (January 12 th -17 th ) REHOVOT, Israel and BRIDGEWATER, N.J., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Foamix [...]

Celtaxsys Secures Private Financing to Advance Acebilustat Phase 3 Cystic Fibrosis (CF) Program Preparatory Activities

04/01/2018 - 14:00

ATLANTA, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Celtaxsys, Inc., a clinical stage drug development company focused on developing novel therapies for rare inflammatory diseases, today announced the successful completion of a [...]

aTyr Pharma to Present at the 36th Annual J.P. Morgan Healthcare Conference

04/01/2018 - 14:00

SAN DIEGO, Jan. 04, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE ), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today [...]

Cellectar Biosciences to Participate at Biotech Showcase 2018

04/01/2018 - 14:00

MADISON, Wis., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB ), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the [...]

Tyme Announces Presentation of Clinical Data on SM-88 in Prostate Cancer at 2018 ASCO Genitourinary Cancers Symposium

04/01/2018 - 14:00

Mack Roach, M.D., FASCO , University of California, San Francisco, to present data from ongoing Phase II clinical trial NEW YORK, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (Nasdaq: TYME ), a clinical- [...]

HTG Announces Preliminary Fourth Quarter and Full Year 2017 Unaudited Financial Results and Provides Initial 2018 Revenue Guidance

04/01/2018 - 14:00

Fourth quarter 2017 revenue expected to be between $6.9 and $7.2 million Full year 2017 revenue expected to be between $13.8 and $14.1 million Initial full year 2018 revenue guidance of $20.0 to $25.0 million TUCSON, [...]

Rhythm Pharmaceuticals Announces Progress in Clinical Development of Setmelanotide for Treatment of Rare Genetic Disorders of Obesity

04/01/2018 - 14:00

- Final protocol confirmed for pivotal Phase 3 clinical trial in pro-opiomelanocortin (POMC) deficiency obesity - - Setmelanotide granted Orphan Drug Designation for treatment of leptin receptor (LEPR) deficiency [...]

Paul Stead Joins Adaptimmune as Vice President of Business Development

04/01/2018 - 14:00

PHILADELPHIA, Pa. and OXFORD, England, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq: ADAP ), a leader in T-cell therapy to treat cancer, today announced that Paul Stead, B. Pharm, PhD, MBA, MR [...]

Newly Published Journal of Antimicrobial Chemotherapy Supplement Provides Insights into the Future of Echinocandin Therapy for Invasive Fungal Infections

04/01/2018 - 14:00

SAN DIEGO, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX ), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that a new compendium of papers [...]

Celsion Announces FDA Clearance of the OVATION II Study for the Evaluation of GEN-1 Immunotherapy to Treat Newly Diagnosed Stage III/IV Ovarian Cancer

04/01/2018 - 14:00

GEN-1 to Enter the Clinic in Mid-2018 Following a Phase IB Trial Which Demonstrated 100% Disease Control, 86% Objective Response Rate and 86% R0 & R1 Surgical Resection Rate in All Patients Treated Compelling [...]

Stemline Therapeutics to Present at the 36th Annual J.P. Morgan Healthcare Conference

04/01/2018 - 14:00

NEW YORK, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML ), a clinical-stage biopharmaceutical company developing novel therapeutics for difficult to treat cancers announced today that Ivan [...]

IntelGenx To Present at Biotech Showcase(TM) 2018

04/01/2018 - 14:00

SAINT-LAURENT, Quebec, Jan. 04, 2018 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX VENTURE:IGX) (OTCQX:IGXT) (the "Company" or "IntelGenx") today announced that its President and Chief Executive Officer, Dr. Horst Zerbe, is [...]

Onconova Therapeutics Announces Cooperative Research and Development Agreement for Rigosertib with the National Cancer Institute

04/01/2018 - 14:00

Agreement related to study of rigosertib in pediatric RASopathies Clinical trial in pediatric patients to be conducted by the National Cancer Institute RASopathies are orphan diseases believed to be caused by molecular [...]

Dynavax to Present at J.P. Morgan 36th Annual Healthcare Conference

04/01/2018 - 12:00

BERKELEY, Calif., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX ) announced today that Eddie Gray, Dynavax’s chief executive officer, will present at the J.P. Morgan 36th Annual [...]

OraSure Technologies Announces Management Succession Plan

04/01/2018 - 12:00

BETHLEHEM, Pa., Jan. 04, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR ), a leader in point of care diagnostic tests and specimen collection devices, today announced a succession plan for its [...]

Orion to renew operating model of its laboratories

04/01/2018 - 10:16

ORION CORPORATION PRESS RELEASE 4 JANUARY 2018 at 11.15 Orion to renew operating model of its laboratories Orion improves the competitiveness of its laboratory operations by renewing their operating model in Finland. As [...]

BioNTech Secures USD 270 Million in Series A Financing

04/01/2018 - 08:30

MAINZ, Germany, Jan. 04, 2018 (GLOBE NEWSWIRE) -- BioNTech AG, a fully-integrated biotechnology company pioneering individualized cancer immunotherapy, today announced it has completed a USD 270 million Series A round [...]

OSE Immunotherapeutics to present at Biotech Showcase™ 2018 Conference

04/01/2018 - 08:00

During JP Morgan Healthcare Conference San Francisco, January 8-10, 2018 NANTES, France, Jan. 04, 2018 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics (ISIN:FR0012127173) (Mnémo:OSE), today announced that Dominique [...]